Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children

NCT ID: NCT01701778

Last Updated: 2018-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the effects of caudal dexmedetomidine with intravenous dexmedetomidine on caudal levobupivacaine analgesia in children undergoing lower abdominal surgeries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Single shot caudal epidural block is one of the most widespread technique for pediatric pain management after infraumbilical surgical procedures.However, in a significant proportion of patients, despite good initial analgesia from a caudal block with local anesthetic, pain develops after the block resolves.

Dexmedetomidine is used increasingly in pediatric anesthesia practice to prolong the duration of action of caudal block with a local anesthetic agent.But which route of administration of clonidine is the most beneficial remains unknown.

The investigators performed prospective randomized double-blind study to compare the effects of caudal dexmedetomidine with intravenous dexmedetomidine on postoperative analgesia after caudal levobupivacaine for inguinal herniorrhaphy or orchidopexy surgery.

90 children (ASAⅠorⅡ,aged 2-5 yr) undergoing unilateral orchiopexy or inguinal herniorrhaphy were included in this study. Anesthesia was induced with sevoflurane via a facemask, followed by placement of a laryngeal mask airway. Anesthesia was maintained with sevoflurane 2-3% in oxygen-air.Then,caudal block was applied. Patients were randomly assigned in three groups. Group Cau-DEX (n = 30): Caudal Levobupivacaine 0.25% 1ml/kg plus dexmedetomidine 1µg/kg and 10 ml normal saline i.v.;Group IV-DEX(n = 30): Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg(10 ml)i.v.;Group Placebo(n = 30): Levobupivacaine 0.25% and 10 ml normal saline intravenous.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inguinal Hernia Cryptorchidism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caudal Dexmedetomidine

Caudal: Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg

Intravenous: 10 ml normal saline

Anesthesia was induced and maintained with sevoflurane

Group Type EXPERIMENTAL

Caudal Dexmedetomidine

Intervention Type DRUG

Caudal: Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg

Intravenous: 10 ml normal saline

sevoflurane

Intervention Type DRUG

Induction and maintain anaesthesia

Intravenous Dexmedetomidine

Caudal: Levobupivacaine 0.25% 1ml/kg

Intravenous: dexmedetomidine 1µg/kg

Anesthesia was induced and maintained with sevoflurane

Group Type EXPERIMENTAL

Intravenous Dexmedetomidine

Intervention Type DRUG

Caudal: Levobupivacaine 0.25% 1ml/kg

Intravenous: dexmedetomidine 1µg/kg

sevoflurane

Intervention Type DRUG

Induction and maintain anaesthesia

Placebo

Caudal: Levobupivacaine 0.25% 1ml/kg

Intravenous: 10 ml normal saline

Anesthesia was induced and maintained with sevoflurane

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Caudal: Levobupivacaine 0.25% 1ml/kg

Intravenous: 10 ml normal saline

sevoflurane

Intervention Type DRUG

Induction and maintain anaesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caudal Dexmedetomidine

Caudal: Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg

Intravenous: 10 ml normal saline

Intervention Type DRUG

Intravenous Dexmedetomidine

Caudal: Levobupivacaine 0.25% 1ml/kg

Intravenous: dexmedetomidine 1µg/kg

Intervention Type DRUG

Placebo

Caudal: Levobupivacaine 0.25% 1ml/kg

Intravenous: 10 ml normal saline

Intervention Type DRUG

sevoflurane

Induction and maintain anaesthesia

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Precedex Precedex Levobupivacaine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA status I-II
* aged 2-5 yr
* Undergoing unilateral orchiopexy/inguinal hernia repair

Exclusion Criteria

* Hypersensitivity to any local anesthetics
* Patient has history of allergy, intolerance, or reaction to dexmedetomidine
* Infections at puncture sites
* Bleeding diathesis
* Preexisting neurological disease
* Diabetes mellitus
* Children with uncorrected cardiac lesions
* Children with heart block or liver impairment
Minimum Eligible Age

2 Years

Maximum Eligible Age

5 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West China Hospital

OTHER

Sponsor Role collaborator

Yao Yusheng

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yao Yusheng

Double-blind randomized controlled trial of caudal versus intravenous dexmedetomidine for supplementation of caudal analgesia in children

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yusheng Yao, M.D.

Role: PRINCIPAL_INVESTIGATOR

Fujian Provincial Hospital

Yanqing Chen, M.D.

Role: PRINCIPAL_INVESTIGATOR

Fujian Provicial Hospital

Jin Liu, M.D.

Role: STUDY_DIRECTOR

West China Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fujian Provincial Hospital

Fuzhou, Fujian, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Yao Y, Yu C, Zhang X, Guo Y, Zheng X. Caudal and intravenous dexmedetomidine similarly prolong the duration of caudal analgesia in children: A randomized controlled trial. Paediatr Anaesth. 2018 Oct;28(10):888-896. doi: 10.1111/pan.13469.

Reference Type DERIVED
PMID: 30302881 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://onlinelibrary.wiley.com/doi/10.1111/j.1399-6576.2008.01818.x/full

Effect of dexmedetomidine on the characteristics of bupivacaine in a caudal block in pediatrics

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FujianPH-TRC-121002

Identifier Type: REGISTRY

Identifier Source: secondary_id

FujianPH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.